Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives.
about
Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Alterations in cardiac structure and function in hypertensionSalt-induced changes in cardiac phosphoproteome in a rat model of chronic renal failure.Bilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive PatientsFeatures of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis.A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fractionThe ameliorating effects of long-term electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats.Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.Evolution of cardiac and renal impairment detected by high-field cardiovascular magnetic resonance in mice with renal artery stenosisGrowth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation.The JAK-STAT pathway in hypertrophic stress signaling and genomic stress response.Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH).Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?Prognostic Application of Thoracic Aortic Calcium Scoring for Adverse Clinical Outcome Risk in Elderly Patients with Left Ventricular Hypertrophy.Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.
P2860
Q30250365-AA2857D8-E685-4061-B6EE-D906662A384DQ33732380-6B949F9D-64D3-4E83-92AE-3838C3755649Q33778975-9E8CDD31-4839-45EB-B07E-FA26E6C824A5Q34269653-0A1C969C-B4C9-4279-A593-C08E7C8CF381Q34570641-4D4FB970-B2EF-4ECE-A004-224A4024710FQ35057999-97A755B7-0860-4CEB-AF38-60E85CAA106EQ35135722-2533C87E-68FE-4D02-891D-291E8AAC3A83Q35558302-0487C20F-C586-4E90-8554-B5B75926CFDDQ36653669-8DD75568-5176-4142-BAA6-A04B9B76FDDFQ37418387-7ECFA532-4FCF-44D3-8E1E-4F562ED2B906Q37683299-34F601D0-2C00-45FD-91FF-56E37808935AQ38140886-3FCE1FC3-531F-4A94-8C86-C189AD2D42D5Q38189389-7F74BCCD-B100-4BFE-8728-70D734E17115Q38492359-3AE248A2-7E9F-4CF0-B0BF-80F45A50F3F1Q43198233-19AC89BD-5600-410B-98F6-F51DD296B14DQ47110146-DF80E520-9FD3-4FC7-9C3F-084170C879A4Q51017930-4436E829-06F7-4D39-AD0F-8CB59605FCCA
P2860
Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular mechanisms of left v ...... ible therapeutic perspectives.
@en
Molecular mechanisms of left ventricular hypertrophy
@nl
type
label
Molecular mechanisms of left v ...... ible therapeutic perspectives.
@en
Molecular mechanisms of left ventricular hypertrophy
@nl
prefLabel
Molecular mechanisms of left v ...... ible therapeutic perspectives.
@en
Molecular mechanisms of left ventricular hypertrophy
@nl
P1476
Molecular mechanisms of left v ...... ible therapeutic perspectives.
@en
P2093
Federico Cacciapuoti
P304
P356
10.1016/J.JASH.2011.08.006
P577
2011-10-20T00:00:00Z